Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Coley

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Keio Journal of Medicine|October 27, 1997
Drug resistance studies using fresh human ovarian carcinoma and soft tissue sarcoma samplesH M Coley
General Pharmacology|February 1, 1997
N-(Hydroxymethyl) melaminesH M Coley
Biochemical Pharmacology|February 9, 1993
The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agentsH M Coley, N Mongelli, M D'Incalci
Biochemical Pharmacology|December 15, 1989
Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin AH M Coley, P R Twentyman, P Workman
Biochemical Pharmacology|October 19, 1993
The efflux of anthracyclines in multidrug-resistant cell linesH M Coley, P R Twentyman, P Workman
British Journal of Cancer|March 1, 1991
Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpressionH M Coley, P Workman, P R Twentyman
Anti-Cancer Drug Design|December 1, 1992
Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistanceH M Coley, P R Twentyman, P Workman
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistanceH M Coley, P R Twentyman, P Workman
Cancer Chemotherapy and Pharmacology|January 1, 1989
Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin AH M Coley, P R Twentyman, P Workman
Cell Death & Disease|January 27, 2012
Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cellsG M A Ajabnoor, T Crook, H M Coley
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Keio Journal of Medicine|October 27, 1997
Drug resistance studies using fresh human ovarian carcinoma and soft tissue sarcoma samplesH M Coley
General Pharmacology|February 1, 1997
N-(Hydroxymethyl) melaminesH M Coley
Biochemical Pharmacology|February 9, 1993
The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agentsH M Coley, N Mongelli, M D'Incalci
Biochemical Pharmacology|December 15, 1989
Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin AH M Coley, P R Twentyman, P Workman
Biochemical Pharmacology|October 19, 1993
The efflux of anthracyclines in multidrug-resistant cell linesH M Coley, P R Twentyman, P Workman
British Journal of Cancer|March 1, 1991
Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpressionH M Coley, P Workman, P R Twentyman
Anti-Cancer Drug Design|December 1, 1992
Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistanceH M Coley, P R Twentyman, P Workman
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistanceH M Coley, P R Twentyman, P Workman
Cancer Chemotherapy and Pharmacology|January 1, 1989
Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin AH M Coley, P R Twentyman, P Workman
Cell Death & Disease|January 27, 2012
Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cellsG M A Ajabnoor, T Crook, H M Coley
Pageof 4